Managers / Q4 2019 · view latest →
TOTH FINANCIAL ADVISORY CORP
CIK 0000866780 · 608 SOUTH KING STREET, SUITE 300, LEESBURG, VA, 20175 · (703) 443-8684
Reported Value
$493M
Q4 2019
Positions
492
Filings on Record
30
2019–present window
Filed
Jan 27, 2020
original filing
Summary
Toth Financial Advisory Corp reported $493M in U.S.-listed holdings across 492 positions for Q4 2019.
Its largest position, FISV, represents 3.0% of the portfolio.
Compared with Q3 2019, the fund opened 76 new positions and exited 60.
Portfolio Metrics
Turnover
+4.5%
vs prior filed quarter
Top-10 Concentration
+24.4%
share of reported value
Largest Position
+3.0%
Fiserv
New / Exited
76 / 60
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 61.2% · $302M
- ETP · 36.3% · $179M
- Other · 2.3% · $11M
- ADR · 0.1% · $532,000
- REIT · 0.1% · $344,000
- Other · 0.1% · $293,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VICTORY PORTFOLIOS II | NEW | +36.8K | 36.8K | +$2M | $2M |
| FLEX LTD | NEW | +48.1K | 48.1K | +$607,000 | $607,000 |
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +2.7K | 2.7K | +$598,000 | $598,000 |
| NBIXNEUROCRINE BIOSCIENCES INC | NEW | +5.6K | 5.6K | +$597,000 | $597,000 |
| ISRGINTUITIVE SURGICAL INC | NEW | +999 | 999 | +$591,000 | $591,000 |
| A4SAMERIPRISE FINL INC | NEW | +3.4K | 3.4K | +$573,000 | $573,000 |
| ALAIR LEASE CORP | NEW | +11.7K | 11.7K | +$556,000 | $556,000 |
| INCYINCYTE CORP | NEW | +6.3K | 6.3K | +$546,000 | $546,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
37 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | PROSHARES TR | PSHS ULTRA QQQ · S&P 500 DV ARIST · PSHS ULT S&P 500 · ULTRA FNCLS NEW · S&P MDCP 400 DIV · RUSS 2000 DIVD · PSHS ULTRA TECH | 11.48% | $57M | 674.9K |
| 2 | XLFSELECT SECTOR SPDR TR | TECHNOLOGY · SBI CONS DISCR · SBI INT-INDS · SBI INT-FINL · SBI HEALTHCARE · SBI INT-UTILS | 10.20% | $50M | 708.9K |
| 3 | ISHARES TR | TRANS AVG ETF · NASDAQ BIOTECH · PHLX SEMICND ETF | 4.00% | $20M | 115.3K |
| 4 | FISVFISERV INChistory → | COM | 2.98% | $15M | 127.2K |
| 5 | MSFTMICROSOFT CORPhistory → | COM | 2.87% | $14M | 89.7K |
| 6 | SYKSTRYKER CORPhistory → | COM | 2.57% | $13M | 60.3K |
| 7 | ABTABBOTT LABShistory → | COM | 2.37% | $12M | 134.3K |
| 8 | CSCOCISCO SYS INChistory → | COM | 2.29% | $11M | 235.9K |
| 9 | SYYSYSCO CORPhistory → | COM | 2.17% | $11M | 125.3K |
| 10 | DISDISNEY WALT COhistory → | COM DISNEY | 2.03% | $10M | 69.3K |
| 11 | JNJJOHNSON & JOHNSONhistory → | COM | 1.67% | $8M | 56.3K |
| 12 | ECLECOLAB INChistory → | COM | 1.61% | $8M | 41.2K |
| 13 | AAPLAPPLE INChistory → | COM | 1.51% | $7M | 25.4K |
| 14 | MEDTRONIC PLC | SHS | 1.42% | $7M | 61.6K |
| 15 | MDLZMONDELEZ INTL INChistory → | CL A | 1.39% | $7M | 124.3K |
| 16 | PEPPEPSICO INChistory → | COM | 1.38% | $7M | 49.7K |
| 17 | BDXBECTON DICKINSON & COhistory → | COM | 1.36% | $7M | 24.7K |
| 18 | SPDR SERIES TRUST | S&P INS ETF | 1.34% | $7M | 186.8K |
| 19 | FIRST TR EXCHANGE TRADED FD | DJ INTERNT IDX | 1.27% | $6M | 45.0K |
| 20 | VVISA INChistory → | COM CL A | 1.23% | $6M | 32.4K |
| 21 | AFLAFLAC INChistory → | COM | 1.22% | $6M | 113.9K |
| 22 | SHWSHERWIN WILLIAMS COhistory → | COM | 1.18% | $6M | 10.0K |
| 23 | PGPROCTER & GAMBLE COhistory → | COM | 1.13% | $6M | 44.5K |
| 24 | MAMASTERCARD INChistory → | CL A | 1.12% | $6M | 18.5K |
| 25 | TROWPRICE T ROWE GROUP INChistory → | COM | 1.08% | $5M | 43.6K |
| 26 | AMGNAMGEN INChistory → | COM | 1.05% | $5M | 21.5K |
| 27 | EFXEQUIFAX INChistory → | COM | 1.00% | $5M | 35.2K |
| 28 | DGXQUEST DIAGNOSTICS INC | COM | 0.99% | $5M | 45.8K |
| 29 | WMTWALMART INC | COM | 0.99% | $5M | 40.9K |
| 30 | ORCLORACLE CORP | COM | 0.96% | $5M | 89.6K |
| 31 | MCDMCDONALDS CORP | COM | 0.92% | $5M | 22.9K |
| 32 | DDOMINION ENERGY INC | COM | 0.87% | $4M | 51.9K |
| 33 | CLCOLGATE PALMOLIVE CO | COM | 0.81% | $4M | 57.7K |
| 34 | ABBVABBVIE INC | COM | 0.80% | $4M | 44.3K |
| 35 | CLXCLOROX CO DEL | COM | 0.78% | $4M | 25.1K |
| 36 | INTCINTEL CORP | COM | 0.76% | $4M | 62.4K |
| 37 | CVSCVS HEALTH CORP | COM | 0.73% | $4M | 48.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $911M | 918 | Apr 16, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $921M | 919 | Jan 20, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $928M | 770 | Oct 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $857M | 727 | Jul 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $831M | 712 | Apr 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $850M | 699 | Jan 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $847M | 710 | Oct 21, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $787M | 740 | Jul 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $799M | 719 | Apr 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $737M | 725 | Jan 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $657M | 756 | Oct 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $691M | 773 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $641M | 811 | Apr 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $617M | 711 | Jan 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $552M | 765 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $574M | 722 | Jul 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $669M | 728 | Apr 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $734M | 753 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $658M | 762 | Oct 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $655M | 704 | Jul 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $627M | 681 | Apr 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $583M | 611 | Jan 25, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $521M | 569 | Oct 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $462M | 566 | Jul 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $346M | 473 | Apr 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $493M | 492 | Jan 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $456M | 475 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $447M | 462 | Jul 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $427M | 423 | Apr 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $366M | 415 | Jan 22, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.